Tango Therapeutics, Inc.·4

Jan 6, 4:10 PM ET

Lee Sung 4

4 · Tango Therapeutics, Inc. · Filed Jan 6, 2026

Insider Transaction Report

Form 4
Period: 2026-01-02
Lee Sung
Director
Transactions
  • Award

    Common Stock

    2026-01-02+10,00010,000 total
  • Award

    Stock Option (Right to Buy)

    2026-01-02+60,00060,000 total
    Exercise: $8.93Exp: 2036-01-02Common Stock (60,000 underlying)
Footnotes (2)
  • [F1]These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in three substantially equal annual installments following the grant date, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
  • [F2]This option shall vest and become exercisable in 36 substantially equal monthly installments over a period of three years following the grant date, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4